Table PPP-9. Composition of illicit drug tablets, 2009 [see all tables in this series...]

Part (i) Content of synthetic scheduled illicit drugs

Country
		Number of tablets	MDMA-like Substance {as the only scheduled substances}	(Meth)Amphetamine {as the only scheduled substances}	MDMA-like Substance and (Meth)Amphetamine {as the only scheduled substances}	Other {scheduled substances}	Miscellaneous	Total
Belgium	(1)	233	33.5	3.9	5.6	0.9	56.2	100
Bulgaria	(1)	235	21.7	32.3	0.9	8.9	36.2	100
Czech Republic		:	:	:	:	:	:	:
Denmark		141	9.0	3.0	3.0	77.0	8.0	100
Germany		208000	31.8	3.0	0.0	65.2	0.0	100
Estonia	(1)	165	10.7	0.9	8.0	80.0	0.2	100
Ireland		:	:	:	:	:	:	:
Greece		46378	43.1	43.2	13.2	0.6	0.0	100
Spain		255	31.1	0.0	30.2	2.5	36.1	100
France-A	(1)	140	22.0	18.0	0.0	3.0	57.0	100
France-B		86	29.1	17.4	1.2	3.5	48.8	100
Italy		70	58.0	12.0	0.0	7.0	23.0	100
Cyprus		:	0.0	0.0	0.0	93.5	6.5	100
Latvia	(1)	176	6.3	0.1	0.0	0.0	93.6	100
Lithuania		:	:	:	:	:	:	:
Luxembourg		90	31.1	7.8	23.3	24.4	13.4	100
Hungary	(1)	242	17.8	31.0	6.2	11.6	33.5	100
Malta		21682	100.0	0.0	0.0	0.0	0.0	100
Netherlands		7010	63.0	2.0	1.0	4.0	30.0	100
Austria		112	17.5	2.6	0.0	3.5	76.3	100
Poland	(1)	41	27.0	37.0	12.0	17.0	7.0	100
Portugal		258	3.2	1.0	0.0	0.0	95.8	100
Romania		:	:	:	:	:	:	:
Slovenia-A		26	4.0	12.0	62.0	4.0	18.0	100
Slovenia-B		27	5.9	47.1	11.8	5.9	29.4	100
Slovakia		1639	0.6	0.7	0.0	0.0	98.7	100
Finland		122	43.4	3.3	4.1	0.0	49.2	100
Sweden		:	:	:	:	:	:	:
United Kingdom	(1)	2730	16.0	1.0	1.0	2.0	80.0	100
Croatia	(1)	48	29.2	12.5	2.1	2.1	54.2	100
Turkey		6573	25.0	36.0	8.0	9.0	22.0	100
Norway		21958	28.0	2.0	0.0	21.0	49.0	100

Notes:

 The table seeks to monitor synthetic scheduled illicit drugs - i.e. drugs controlled under the 1971 UN Convention on Psychotropic Substances Schedules I and II and under European legislation (Council Decisions), providing data on the contents of illicit drug tablets from different sources (seizures, users' submissions, etc.). 

 (1) This figure "Number of tablets" refers to the total number of records analysed; that is the number of different tablet types analysed. 

 For methodological information: source, sampling frame and type of study, please refer to Table PPP-9 part(ii). and Table PPP-9 part(iii).  

 For additional available information on substances included in categories "Miscellaneous" and "Other", please refer to Table PPP-9 part(iv).  

Sources:

 Reitox national focal points.  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)